‘Do-it-yourself’insulin pump. Case report D Bruttomesso, G Lisato, S Del Prato, A Tiengo Acta diabetologia latina 26, 75-78, 1989 | 1 | 1989 |
(ACE/AACE Diabetes Recommendations Implementation Writing Committee). ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus … HE Lebovitz, MM Austin, L Blonde, JA Davidson, S Del Prato, ... Endocr Pract 12 (Suppl 1), 6-12, 2006 | 15 | 2006 |
[11] ELEVATED ONE-HOUR POST-LOAD PLASMA GLUCOSE LEVELS IDENTIFIES SUBJECTS WITH NORMAL GLUCOSE TOLERANCE AND IMPAIRED β-CELL FUNCTION, INSULIN-RESISTANCE AND WORSE … C Bianchi, R Bonadonna, G Penno, MG Giovannitti, I Crisci, G Daniele, ... Nutrition, Metabolism and Cardiovascular Diseases, S3, 2009 | | 2009 |
[80] FINDRISC (FINNISH DIABETES RISK SCORE): ITS USE AS A PREDICTOR OF BOTH DIABETES RISK AND CARDIOVASCULAR RISK IN AN ITALIAN POPULATION G Penno, C Bianchi, L Pucci, A Agostini, D Lucchesi, E Storti, E Russo, ... Nutrition, Metabolism and Cardiovascular Diseases, S20-S21, 2009 | | 2009 |
& Loach, K R O’Brien Director, 2000 | 22 | 2000 |
1 h post-load blood glucose for detection of individuals at increased risk of diabetes and cardiovascular disease DS Popovic, S Del Prato Diabetes Research and Clinical Practice 120, 184-185, 2016 | 2 | 2016 |
1-hr glucose level after 100 g OGTT as marker of disturbance of glucose homeostasis in pregnant women C Lencioni, G Seghieri, I Cuccuru, R Anichini, A De Bellis, A Ghio, V Resi, ... DIABETOLOGIA 51, S464-S464, 2008 | | 2008 |
1‐Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women A Ghio, G Seghieri, C Lencioni, R Anichini, A Bertolotto, A De Bellis, ... International Journal of Endocrinology 2012 (1), 460509, 2012 | 11 | 2012 |
1. ATHEROSCLEROSIS IS THE MOST COMMON COMPLICATION OF DIABETES G Crepaldi, A Tiengo, S Del Prato, G Steiner Insulin Resistance, Metabolic Diseases, and Diabetic Complications …, 1999 | | 1999 |
10.29 Metabolic Syndrome and Vascular Alterations in Normotensive Patients at Risk of Diabetes Mellitus L Ghiadoni, C Giannarelli, Y Plantinga, M Bernardini, L Pucci, C Penno, ... High Blood Pressure & Cardiovascular Prevention 14, 145-145, 2007 | | 2007 |
1146-P: Switching to iGlarLixi vs. Continued Treatment of GLP-1RA: Comparative Analysis by Daily or Weekly GLP-1RAs in the LixiLan-G Trial J ROSENSTOCK, L BLONDE, SDEL PRATO, RR HENRY, N SHEHADEH, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
1238-P: The Face of Diabetic Cardiomyopathy—Baseline Characteristics from the ARISE-HF Trial J BUTLER, S DEL PRATO, J EZEKOWITZ, NE IBRAHIM, CS LAM, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
1392-P: Assisted Reproduction Technology Treatment and Risk of Gestational Diabetes C Bianchi, CD PELLE, GDE GENNARO, M Aragona, V Cela, S Delprato, ... Diabetes 69 (Supplement_1), 2020 | 3 | 2020 |
149-OR: LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD (s) L Blonde, J Rosenstock, SDEL PRATO, RR Henry, N Shehadeh, ... Diabetes 68 (Supplement_1), 2019 | 2 | 2019 |
1516-P: Microvascular Burden Predicts All-Cause Mortality, Major Vascular Outcomes, and ESRD in Type 2 Diabetes M Garofolo, E Gualdani, R Giannarelli, D Lucchesi, R Miccoli, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
1704-P: SIRT1 rs7896005 SNP and Incidence of Major Vascular Events in Type 2 Diabetes: A 13-Year, Single-Centre, Follow-Up Study G Penno, M Garofolo, E Gualdani, D Lucchesi, L Giusti, V Sancho-Bornez, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
175-OR: Effect of Alirocumab in Individuals with Type 2 Diabetes and High Triglycerides and Low High-Density Lipoprotein Cholesterol HM COLHOUN, LA LEITER, D MÜLLER-WIELAND, B CARIOU, KK RAY, ... Diabetes 68 (Supplement_1), 2019 | 1 | 2019 |
1817-P: Metabolic Surgery Affects Brain Glucose Metabolism, Cognitive Function, and Neuroplasticity in Humans G DANIELE, A DARDANO, D VOLTERRANI, A CICCARONE, L GIUSTI, ... Diabetes 68 (Supplement_1), 2019 | 1 | 2019 |
1999 Elsevier Science BV All rights reserved. Insulin Resistance, Metabolic Diseases and Diabetic Complications G Crepaldi, A Tiengo, S Del Prato, GL King, H Wakasaki Insulin Resistance, Metabolic Diseases, and Diabetic Complications …, 1999 | | 1999 |
1999 Elsevier Science BV Insulin Resistance, Metabolic Diseases and Diabetic Complications G Crepaldi, A Tiengo, S Del Prato, E Apolipoprotein, C Gabelli, A Codemo, ... Insulin Resistance, Metabolic Diseases, and Diabetic Complications …, 1999 | | 1999 |